|Articles|October 14, 2022
- Applied Clinical Trials-10-01-2022
- Volume 31
- Issue 10
Applied Clinical Trials October 2022 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials October 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 3 years ago
Managing Biospecimens in Cell and Gene Therapy Trialsabout 3 years ago
The Risk-Reward Proposition for CGT Clinical Trialsabout 3 years ago
Philadelphia Shines in Cell and Gene Therapy Research Pursuitsabout 3 years ago
Survey Investigates Backup Solution Adoption for ePRO Systemsabout 3 years ago
Scientists Don’t Ever Stop Sciencingover 3 years ago
Key Clinical Trial Industry Themes Post-COVIDNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clarifying Ownership of IRT Data in Clinical Trials: Distinguishing Investigator-Controlled Data from Sponsor Operational Data
2
Building More Representative Cancer Trial Populations
3
ACT Brief: Reframing Site Initiation Readiness, Operational Execution as Competitive Advantage, and a Historic Motion Sickness Approval
4
Fresh Starts, Real Readiness: Turning Site Initiation into a Trial Success Multiplier
5
